What does BPC-157 do?

Your stomach naturally produces a protein called "body protection compound." BPC-157 is a synthetic fragment of that protein — just 15 amino acids — that appears to accelerate healing in damaged tissue.

In animal studies, it does a few things consistently: it promotes new blood vessel growth to injured areas (angiogenesis), speeds up collagen production in tendons and ligaments, and reduces inflammation in the gut lining. It's unusually stable in stomach acid, which is rare for peptides and makes the oral route possible.

The gut healing evidence is the most developed. In rat models, BPC-157 heals ulcers faster than omeprazole, reduces intestinal permeability caused by NSAIDs, and improves inflammatory bowel disease markers. For tendons and muscles, it accelerates repair by stimulating growth factors at the injury site.

Who uses it?

• People with gut issues — leaky gut, IBD, chronic gastritis, or NSAID-related damage
• Athletes — tendon injuries (Achilles, rotator cuff), ligament tears, chronic joint pain
• Post-surgery recovery — some use it to accelerate wound healing (off-label)
• Longevity-focused individuals — for general tissue maintenance and gut integrity

What to know before trying

Oral vs injectable: For gut-specific problems, oral capsules (ideally the arginine salt form) deliver the peptide directly to your GI tract. For systemic effects like tendon repair, subcutaneous injection is preferred. Many people use both routes depending on the goal.

Sourcing matters: Because BPC-157 is unregulated, quality varies wildly between suppliers. Look for third-party HPLC testing certificates showing ≥98% purity. Without this, you can't be sure what you're actually getting.

Typical cycle: Most protocols run 4–12 weeks, followed by an off period. There's no validated human dosing — these are community-derived protocols based on animal research doses.

Frequently Asked Questions

How it works in your body

BPC-157 operates through several intersecting pathways. It upregulates VEGF (vascular endothelial growth factor), which promotes new blood vessel formation at injury sites. It sensitises growth hormone receptors in tissue without raising circulating GH levels. It modulates nitric oxide synthase, affecting blood vessel tone and gut motility. And it directly stimulates tendon fibroblasts via the Egr-1 transcription pathway, accelerating collagen production.

For the gut specifically, it interacts with the dopamine and GABA systems and stabilises the gut-brain axis. This multi-pathway action explains why it shows effects across so many different tissue types in animal models.

Animal vs human evidence

• Gut healing: Consistent acceleration of ulcer healing in rat models, outperforming omeprazole in some studies. Reduces intestinal permeability from NSAIDs and alcohol.
• Tendon repair: Accelerates Achilles tendon healing via Egr-1 and VEGFR2 pathways. Stimulates collagen organisation.
• Anti-inflammatory: Broadly reduces TNF-α and IL-6 in multiple inflammation models.
• Human data: Only one small retrospective case series. This is the critical gap — compelling animal data does not automatically translate to human outcomes.

Sourcing and quality

BPC-157 is sold as a research chemical, primarily in lyophilised powder form requiring reconstitution with bacteriostatic water. Quality verification is a significant concern — without pharmaceutical-grade manufacturing, purity and peptide content can vary substantially. Third-party HPLC testing certificates are the minimum bar. Look for suppliers who provide batch-specific certificates of analysis.

What to monitor

If a physician is supervising your use, they may track:

• Liver enzymes (ALT, AST) — baseline and at 6–8 weeks
• hs-CRP — to assess whether inflammation is actually improving
• GI symptom tracking — if used for gut conditions
• Blood pressure — BPC-157 modulates nitric oxide, which affects vascular tone

Side effects & safety

BPC-157 has not been formally evaluated for safety in human clinical trials. Animal studies show a favourable safety profile with no reported serious adverse events at therapeutic doses. Here's what users commonly report:

• Injection site reactions — mild redness, swelling, or tenderness at the injection site. Usually resolves within hours.
• Nausea — more common with oral dosing at higher amounts. Taking it with a small amount of food can help.
• Dizziness — lightheadedness reported occasionally, possibly related to blood pressure effects via nitric oxide modulation.
• Headache — uncommon, usually in the first few days. Tends to resolve on its own.
• Unknown long-term effects — this is the honest reality. Without human clinical trials, we cannot know the long-term safety profile. Anyone with active cancer should avoid it, as its angiogenesis-promoting effects could theoretically be problematic.

Who should avoid it: People with active cancer or a history of cancer (due to angiogenesis stimulation), pregnant or breastfeeding women, and anyone on blood thinners or blood pressure medication without physician guidance.

Related